To access this element change to forms mode OFF
Grant Award View - GA217903
Fibrinogen Early In Severe Trauma StudY II (FEISTY II)
GA ID:
GA217903
Agency:
Department of Health and Aged Care
Approval Date:
6-Dec-2021
Publish Date:
16-Feb-2022
Category:
Health and Medical Research
Grant Term:
1-Feb-2022 to 31-Jan-2027
Value (AUD):
$3,162,379.40
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
MRFF Research Grants
Grant Activity:
Fibrinogen Early In Severe Trauma StudY II (FEISTY II)
Purpose:
Yearly, 8000 Australians suffer severe trauma and bleeding caused by trauma is a major cause of death. Trauma results the inability to form clots to stop bleeding. Fibrinogen is a clotting factor that bind clots together. Fibrinogen can be replaced using cryoprecipitate, a frozen blood product made from healthy donors, or fibrinogen factor concentrate which is easier to use and has a long shelf life. FEISTY II will investigate fibrinogen replacement in severely injured bleeding trauma patients.
GO ID:
GO Title:
MRFF 2021 Rare Cancers Rare Diseases Unmet Need General - Grant Opportunity
Internal Reference ID:
2021/MRF2015332
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA